Literature DB >> 6807846

Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

D E Woods, S J Cryz, R L Friedman, B H Iglewski.   

Abstract

A chronic pulmonary infection model in rats was employed to assess the role of individual Pseudomonas aeruginosa exoproducts in disease due to this organism. Groups of rats were inoculated transtracheally with agar beads in which were embedded approximately 10(4) colony-forming units of P. aerugijnosa PAO and the PAO derivatives PR1, T1, E64, and a mixture of T1 and E64 in equal numbers (10(4)). Eight animals from each group were sacrificed at 3, 9, and 30 days after challenge, and their lungs were examined for histopathological changes, bacterial numbers, and the presence of P. aeruginosa exoproducts. The Tox- mutant T1 and the PR1 mutant, which produces enzymatically inactive toxin A, were both found to be less virulent in the rat lung model than was the toxigenic parental strain PAO. Pathological changes seen in animals infected with these mutants were restricted to intra- and peribronchial inflammation, whereas the toxigenic parental strain caused parenchymal changes, including a dense mononuclear-cell infiltration in the alveolar spaces in addition to intra- and peribronchial inflammation. Additionally, mutant E64, which produces a temperature-sensitive elastase, was also found to be less virulent in the rat lung model than was the parental strain. These data demonstrate that both active toxin A and elastase are required for maximum virulence of P. aeruginosa in this model.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807846      PMCID: PMC551460          DOI: 10.1128/iai.36.3.1223-1228.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Cystic fibrosis: the ciliary inhibitor is a small polypeptide associated with immunoglobulin G.

Authors:  B H Bowman; B J Lankford; G M Fuller; S D Carson; A Kurosky; D R Barnett
Journal:  Biochem Biophys Res Commun       Date:  1975-06-16       Impact factor: 3.575

2.  Pneumonia in an intensive care unit. A 30-month experience.

Authors:  R M Stevens; D Teres; J J Skillman; D S Feingold
Journal:  Arch Intern Med       Date:  1974-07

Review 3.  Extracellular toxins of Pseudomonas aeruginosa.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

4.  Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa.

Authors:  B Wretlind; T Wadström
Journal:  J Gen Microbiol       Date:  1977-12

5.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

6.  Pseudomonas: the compromised host.

Authors:  R E Wood
Journal:  Hosp Pract       Date:  1976-08

7.  Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.

Authors:  P V Liu; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

8.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Incidence of exotoxin production by Pseudomonas species.

Authors:  M J Bjorn; M L Vasil; J C Sadoff; B H Iglewski
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more
  67 in total

1.  A substitution at His-120 in the LasA protease of Pseudomonas aeruginosa blocks enzymatic activity without affecting propeptide processing or extracellular secretion.

Authors:  J K Gustin; E Kessler; D E Ohman
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

Review 2.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

3.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 4.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

6.  Effects of Pseudomonas aeruginosa elastase on alveolar epithelial permeability in guinea pigs.

Authors:  A O Azghani; J C Connelly; B T Peterson; L D Gray; M L Collins; A R Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.

Authors:  S J Cryz; T L Pitt; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.

Authors:  H K Johansen; F Espersen; S J Cryz; H P Hougen; A Fomsgaard; J Rygaard; N Høiby
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.

Authors:  A Kharazmi; N Høiby; G Döring; N H Valerius
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

10.  Regulation of Vibrio anguillarum empA metalloprotease expression and its role in virulence.

Authors:  Steven M Denkin; David R Nelson
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.